Airiver Medical Receives FDA IDE Approval for Chronic Rhinosinusitis Treatment Study Airiver Medical has received FDA IDE approval for a pivotal clinical trial of its Drug Coated Balloon technology aimed at chronic rhinosinusitis patients. This study is a significant step towards offering a new treatment option!

Airiver Medical Receives FDA IDE Approval for Chronic Rhinosinusitis Treatment Study #United_States #Chronic_Rhinosinusitis #Brooklyn_Park #Airiver_Medical #Drug_Coated_Balloon